← All organizations

EyeBiotech Ltd.

For profitWebsite ↗

Also known as: EyeBiotech Ltd.

Highest phase reached

Phase 3

First clinical trial

Jun 12, 2023

Last known activity

Sep 12, 2025

Acquired by Merck on May 29, 2024

Timeline

2020s

  1. Jun 1, 2021

    EyeBiotech Ltd.— Founded

  2. May 29, 2024

    Merck— Acquired By

Drugs by trial phase (4 distinct, 5 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Recent trials (8)

Details

Founded
London, GB Jun 1, 2021
Last known activity
Sep 12, 2025